Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Jan;7(1):379-87.
doi: 10.1128/mcb.7.1.379-387.1987.

Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system

R B DuBridge, P Tang, H C Hsia, P M Leong, J H Miller, M P Calos

Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system

R B DuBridge et al. Mol Cell Biol. 1987 Jan.

Abstract

We developed highly sensitive shuttle vector systems for detection of mutations formed in human cells using autonomously replicating derivatives of Epstein-Barr virus (EBV). EBV vectors carrying the bacterial lacI gene as the target for mutation were established in human cells and later returned to Escherichia coli for rapid detection and analysis of lacI mutations. The majority of the clonal cell lines created by establishment of the lacI-EBV vector show spontaneous LacI- frequencies of less than 10(-5) and are suitable for studies of induced mutation. The ability to isolate clonal lines represents a major advantage of the EBV vectors over transiently replicating shuttle vectors (such as those derived from simian virus 40) for the study of mutation. The DNA sequence changes were determined for 61 lacI mutations induced by exposure of one of the cell lines to N-nitroso-N-methylurea. A total of 33 of 34 lacI nonsense mutations and 26 of 27 missense mutations involve G X C to A X T transitions. These data provide support for the mutational theory of cancer.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Mol Biol. 1967 Jun 14;26(2):365-9 - PubMed
    1. J Mol Biol. 1977 Jan 15;109(2):303-26 - PubMed
    1. J Mol Biol. 1977 Jan 15;109(2):275-98 - PubMed
    1. J Gen Virol. 1977 Jul;36(1):59-74 - PubMed
    1. J Natl Cancer Inst. 1977 Sep;59(3):941-4 - PubMed

Publication types

Substances